John Adams

Director Técnico/Científico/I+D en INHIBIKASE THERAPEUTICS, INC. .

Health Technology

Consumer Services

Technology Services

Perfil

John Adams is the founder of Corhepta Pharmaceuticals, Inc. Dr. Adams is the Chief Scientific Officer at Inhibikase Therapeutics, Inc. since 2025.
Former jobs include Head-Research at Arena Pharmaceuticals, Inc., Senior Vice President-Translational Science at Reneo Pharmaceuticals, Inc., and Senior Vice President-Discovery Biology at Iambic Therapeutics, Inc. Education includes a doctorate from the University of California, Los Angeles and an undergraduate degree from the University of California, Santa Barbara.

Cargos activos de John Adams

Empresas	Cargo	Inicio
INHIBIKASE THERAPEUTICS, INC.	Director Técnico/Científico/I+D	24/02/2025

Todos los cargos activos de John Adams

Antiguos cargos conocidos de John Adams.

Empresas	Cargo	Fin
ARENA PHARMACEUTICALS	Director Técnico/Científico/I+D	-
Entos, Inc. Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery	Corporate Officer/Principal	-
ONKURE THERAPEUTICS, INC.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de John Adams.

Formación de John Adams.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de John Adams.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	6
Arena Pharmaceuticals, Inc. Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products	Health Technology
University of California, Los Angeles University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of California, Santa Barbara University of California, Santa Barbara Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Inhibikase Therapeutics, Inc. Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases	Health Technology
Reneo Pharmaceuticals, Inc. Reneo Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases	Health Technology
Entos, Inc. Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery	Technology Services